Op Pharma Distributor Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-12-2024
- Paid Up Capital ₹ 0.47 M
as on 15-12-2024
- Company Age 6 Year, 23 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.87 Cr
as on 15-12-2024
- Revenue -32.95%
(FY 2021)
- Profit 18.08%
(FY 2021)
- Ebitda 73.40%
(FY 2021)
- Net Worth 0.54%
(FY 2021)
- Total Assets 7.02%
(FY 2021)
About Op Pharma Distributor
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.47 M.
The company currently has active open charges totaling ₹3.87 Cr.
Poonam Hisaria, Yogvir Singh, Raj Kumar, and One other member serve as directors at the Company.
- CIN/LLPIN
U51909UP2018PTC110696
- Company No.
110696
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Nov 2018
- Date of AGM
31 Oct 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Op Pharma Distributor?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Poonam Hisaria  | Director | 20-May-2019 | Current |
| Yogvir Singh | Additional Director | 27-Mar-2024 | Current |
| Raj Kumar | Director | 02-Mar-2021 | Current |
| Sunder Pal | Additional Director | 03-Sep-2024 | Current |
Financial Performance of Op Pharma Distributor.
Op Pharma Distributor Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 32.95% decrease. The company also saw a substantial improvement in profitability, with a 18.08% increase in profit. The company's net worth moved up by a moderate rise of 0.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Op Pharma Distributor?
In 2021, Op Pharma Distributor had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Healthaura Pharma Services LlpActive 5 years 7 monthsPoonam Hisaria and Raj Kumar are mutual person
- Mvd Hospitality & Facility Management Services Private LimitedActive 13 years 6 months
Yogvir Singh is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Feb 2022 | ₹7.09 M | Open |
Others Creation Date: 26 Jun 2020 | ₹1.63 M | Open |
Others Creation Date: 27 Sep 2019 | ₹3.00 Cr | Open |
How Many Employees Work at Op Pharma Distributor?
Op Pharma Distributor has a workforce of 5 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Op Pharma Distributor, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Op Pharma Distributor's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
